BOLERO-3 results: pharmacological activity or pharmacokinetic effect?

Lancet Oncol. 2014 Jul;15(8):e304. doi: 10.1016/S1470-2045(14)70242-6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Drug Resistance, Neoplasm / drug effects*
  • Female
  • Humans
  • Sirolimus / analogs & derivatives*

Substances

  • Sirolimus